Citrate- Versus Acetate-Based Dialysate in Bicarbonate Haemodialysis: Consequences on Haemodynamics, Coagulation, Acid-Base Status and Electrolytes

This study has been completed.
Sponsor:
Collaborator:
Bichsel AG, Interlaken, Switzerland
Information provided by:
Ospedale Regionale di Locarno
ClinicalTrials.gov Identifier:
NCT00718289
First received: July 16, 2008
Last updated: July 17, 2008
Last verified: July 2008
  Purpose

Background:

A concentrate for bicarbonate haemodialysis acidified with citrate instead of acetate has been marketed in the recent years. The small amount of citrate used (one-fifth of the concentration adopted in regional anticoagulation) protects against intradialyser clotting, minimally affecting the calcium concentration. The aim of this study is to compare the impact of a citrate- and acetate-based dialysate on systemic haemodynamics, coagulation, acid-base status, calcium balance and dialysis efficiency.

Methods:

In 25 patients, 375 dialysis sessions, we will compare acetate (A) with citrate dialysate with (C+) or without (C) calcium supplementation (0.25mmol/L) in a randomized single blind cross-over study. Systemic haemodynamics will be evaluated using pulse wave analysis systems. Coagulation, acid-base status, calcium balance and dialysis efficiency will be assessed using standard biochemical markers.


Condition Intervention Phase
Haemodialysis
Other: Citrate dialysate
Other: Acetate dialysate
Phase 4

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Crossover Assignment
Masking: Single Blind (Subject)
Primary Purpose: Treatment
Official Title: Citrate- Versus Acetate-Based Dialysate in Bicarbonate Haemodialysis: Consequences on Haemodynamics, Coagulation, Acid-Base Status and Electrolytes

Resource links provided by NLM:


Further study details as provided by Ospedale Regionale di Locarno:

Primary Outcome Measures:
  • Consequences on systemic haemodynamics [ Time Frame: Study duration ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Consequences on coagulation, acid-base status, calcium balance and dialysis efficiency [ Time Frame: Study duration ] [ Designated as safety issue: No ]

Enrollment: 25
Study Start Date: March 2007
Study Completion Date: November 2007
Primary Completion Date: November 2007 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Citrate
Citrate dialysate for haemodialysis
Other: Citrate dialysate
dialysis fluid composition for Citrate (C) and Acetate (A): acetate [3.0 mmol/L in A and 0.3 in C], citrate [0 mmol/L in A and 0.8 in C]
Active Comparator: Acetate
Acetate dialysate
Other: Acetate dialysate
dialysis fluid composition for Citrate (C) and Acetate (A): acetate [3.0 mmol/L in A and 0.3 in C], citrate [0 mmol/L in A and 0.8 in C]

  Show Detailed Description

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • chronic haemodialysis patients
  • dialysed 3 to 4 hours three times a week, who were
  • clinically stable and without intercurrent illnesses

Exclusion Criteria:

  • intercurrent illnesses
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00718289

Locations
Switzerland
Ospedale Regionale di Locarno
Locarno, Ticino, Switzerland, 6600
Sponsors and Collaborators
Ospedale Regionale di Locarno
Bichsel AG, Interlaken, Switzerland
Investigators
Principal Investigator: Luca Gabutti, MD Ospedale Regionale di Locarno
  More Information

No publications provided by Ospedale Regionale di Locarno

Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Luca Gabutti; Head of Department, Ospedale Regionale di Locarno
ClinicalTrials.gov Identifier: NCT00718289     History of Changes
Other Study ID Numbers: 012008
Study First Received: July 16, 2008
Last Updated: July 17, 2008
Health Authority: Switzerland: Swissmedic

Keywords provided by Ospedale Regionale di Locarno:
Citric acid
citrate
acetic acid
acetate
haemodialysis
calcium
hypotension
haemodynamics
Dialysate for Haemodialysis

Additional relevant MeSH terms:
Citric Acid
Dialysis Solutions
Anticoagulants
Chelating Agents
Hematologic Agents
Molecular Mechanisms of Pharmacological Action
Pharmaceutical Solutions
Pharmacologic Actions
Sequestering Agents
Therapeutic Uses

ClinicalTrials.gov processed this record on October 23, 2014